Tumor Necrosis on Magnetic Resonance Imaging Correlates With Aggressive Histology and Disease Progression in Clear Cell Renal Cell Carcinoma

National Cancer Institute. Cancer Stat Fact Sheets: cancer of the kidney and renal pelvis. Available at: http://seer.cancer.gov/statfacts/html/kidrp.html. Accessed December 28, 2010. McDermott, 2009, Immunotherapy of metastatic renal cell carcinoma, Cancer, 115, 2298, 10.1002/cncr.24236 Schrader, 2008, Metastatic non-clear cell renal cell carcinoma: current therapeutic options, BJU Int, 101, 1343, 10.1111/j.1464-410X.2008.07462.x Motzer, 2007, Sunitinib versus interferon alfa in metastatic renal-cell carcinoma, N Engl J Med, 356, 115, 10.1056/NEJMoa065044 Sun, 2009, Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings, Radiology, 250, 793, 10.1148/radiol.2503080995 Pedrosa, 2008, MR classification of renal masses with pathologic correlation, Eur Radiol, 18, 365, 10.1007/s00330-007-0757-0 Sasiwimonphan, 2012, Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging, Radiology, 263, 160, 10.1148/radiol.12111205 Dodelzon, 2012, Prediction of growth rate of solid renal masses: utility of MR imaging features–preliminary experience, Radiology, 262, 884, 10.1148/radiol.11111074 Pedrosa, 2008, MR imaging of renal masses: correlation with findings at surgery and pathologic analysis, Radiographics, 28, 985, 10.1148/rg.284065018 Choudhary, 2009, Renal cell carcinoma: recent advances in genetics and imaging, Semin Ultrasound CT MR, 30, 315, 10.1053/j.sult.2009.03.003 Outwater, 1997, Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images, Radiology, 205, 103, 10.1148/radiology.205.1.9314970 Israel, 2004, Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas, AJR Am J Roentgenol, 183, 215, 10.2214/ajr.183.1.1830215 Outwater, 1998, Detection of lipid in abdominal tissues with opposed-phase gradient-echo images at 1.5 T: techniques and diagnostic importance, Radiographics, 18, 1465, 10.1148/radiographics.18.6.9821195 Hood, 1999, Chemical shift: the artifact and clinical tool revisited, Radiographics, 19, 357, 10.1148/radiographics.19.2.g99mr07357 Delfaut, 1999, Fat suppression in MR imaging: techniques and pitfalls, Radiographics, 19, 373, 10.1148/radiographics.19.2.g99mr03373 Hammoud, 1996, Prognostic significance of preoperative MRI scans in glioblastoma multiforme, J Neurooncol, 27, 65, 10.1007/BF00146086 Firth, 1993, Bias reduction of maximum likelihood estimates, Biometrika, 80, 27, 10.1093/biomet/80.1.27 2003 Upton, 2005, Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy, J Immunother, 28, 488, 10.1097/01.cji.0000170357.14962.9b Frank, 2002, An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score, J Urol, 168, 2395 Minardi, 2008, Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1alpha in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up, Int J Immunopathol Pharmacol, 21, 447, 10.1177/039463200802100225 Sengupta, 2005, Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness, Cancer, 104, 511, 10.1002/cncr.21206 Klatte, 2009, Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification, J Urol, 181, 1558 Hemmerlein, 2001, Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas, Virchows Arch, 439, 645, 10.1007/s004280100464 Motzer, 2002, Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma, J Clin Oncol, 20, 289, 10.1200/JCO.20.1.289 Kattan, 2001, A postoperative prognostic nomogram for renal cell carcinoma, J Urol, 166, 63 Zisman, 2002, Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma, J Clin Oncol, 20, 4559, 10.1200/JCO.2002.05.111 Atkins, 2009, Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference, Cancer, 115, 2247, 10.1002/cncr.24229 McDermott, 2006, Interleukin-2 therapy of metastatic renal cell carcinoma–predictors of response, Semin Oncol, 33, 583, 10.1053/j.seminoncol.2006.06.004 Krishnan, 2002, Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases, Hum Pathol, 33, 68, 10.1053/hupa.2002.30210 Hindman, 2012, Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques?, Radiology, 265, 468, 10.1148/radiol.12112087